Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy

Annals of the New York Academy of Sciences

Volumn 1097, Issue , 2007, Pages 12-29

  Benveniste, Helene ^a,b   Ma, Yu ^b   Dhawan, Jasbeer ^a   Gifford, Andrew ^a   Smith, S David ^a   Feinstein, Igor ^a   Du, Congwu ^a,b   Grant, Samuel C ^c,d   Hof, Patrick R ^e  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c FLORIDA STATE UNIVERSITY   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Imaging; Mice; Model; MR microscopy; Phenotyping

Indexed keywords

AMYLOID; ANESTHETIC AGENT; MANGANESE;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; BRAIN ATROPHY; BRAIN DEPTH STIMULATION; BRAIN TISSUE; CLINICAL RESEARCH; COGNITION; CONFERENCE PAPER; DISEASE MODEL; ELECTROSTIMULATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETICS; GENOTYPE; GLIOSIS; HEART DISEASE; LUNG DISEASE; MEDICAL INFORMATION; MICROSCOPY; MOLECULAR BIOLOGY; NERVE CELL; NERVE DEGENERATION; NEURITE; NEUROANATOMY; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NONHUMAN; PATHOLOGY; PHENOTYPE; RODENT; SCREENING; SENILE PLAQUE; SYNAPSE; TRANSGENIC MOUSE; ANIMAL; ATROPHY; BRAIN; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMALIA; MUS; MUS MUSCULUS; RODENTIA;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; ATROPHY; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; MICROSCOPY; PHENOTYPE;

EID: 34247579196     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1379.006     Document Type: Conference Paper

References (74)

1. CIOBANU, L., D.A. SEEBER & C.H. PENNINGTON. 2002. 3D MR microscopy with resolution 3.7 microm by 3.3 microm by 3.3 microm. J. Magn. Reson. 158: 178-182.
2. BOYNTON, G.M. et al. 1996. Linear systems analysis of functional magnetic resonance imaging in human V1. J. Neurosci. 16: 4207-4221.
3. FRISTON, K.J. et al. 1995. Analysis of fMRI time-series revisited. Neuroimage 2: 45-53.
4. CHANCE, B. 1993. NMR and time-resolved optical studies of brain imaging. Adv. Exp. Med. Biol. 333: 1-7.
5. VILLRINGER, A. & B. CHANCE. 1997. Non-invasive optical spectroscopy and imaging of human brain function. Trends Neurosci. 20: 435-442.
6. FOWLER, J.S. et al. 2004. 2-deoxy-2-[18F]fluoro-D-glucose and alternative radiotracers for positron emission tomography imaging using the human brain as a model. Semin. Nucl. Med. 34: 112-121.
7. PICHLER, B.J. et al. 2006. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J. Nucl. Med. 47: 639-647.
8. ESIRI, M.M. et al. 1997. Ageing and dementia. In Greenfield's Neuropathology, Vol. 2. D.I. Graham, & P.L. Lantos, Eds.: 153-213. Arnold. London.
9. HOF, P.R. & J.H. MORRISON. 2004. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci. 27: 607-613.
10. KILLIANY, R.J. et al. 2000. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann. Neurol. 47: 430-439.
11. TEIPEL, S.J. et al. 2002. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 59: 243-248.
12. TEIPEL, S.J. et al. 1998. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 51: 1381-1385.
13. THOMPSON, P.M. et al. 2003. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 23: 994-1005.
14. THOMPSON, P.M. et al. 1998. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb. Cortex 8: 492-509.
15. NORDBERG, A. 2004. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 3: 519-527.
16. GAMES, D. et al. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527.
17. HSIAO, K. et al. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
18. MOECHARS, D. et al. 1999. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274: 6483-6492.
19. SANTACRUZ, K. et al. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476-481.
20. ECHEVERRIA, V. et al. 2004. Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. J. Alzheimers Dis. 6: 209-219.
21. ODDO, S. et al. 2003. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 24: 1063-1070.
22. ODDO, S. et al. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
23. POPKO, B. et al. 1993. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60: 1155-1158.
24. BENVENISTE, H. & S. BLACKBAND. 2002. MR microscopy and high resolution small animal MRI: applications in neuroscience research. Prog. Neurobiol. 67: 393-420.
25. HUESGEN, C.T. et al. 1993. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 43: 145-152.
26. BRAAK, H. & E. BRAAK. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82: 239-259.
27. BENVENISTE, H. et al. 1999. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. USA 96: 14079-14084.
28. MILLER, L.M. et al. 2006. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 155: 30-37.
29. DHENAIN, M. et al. 2002. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed. 15: 197-203.
30. JACK, C.R. JR. et al. 2004. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn. Reson. Med. 52: 1263-1271.
31. JACK, C.R. JR., et al. 2005. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J. Neurosci. 25: 10041-10048.
32. VANHOUTTE, G. et al. 2005. Noninvasive In vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn. Reson. Med. 53: 607-613.
33. PODUSLO, J.F. et al. 2002. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol. Dis. 11: 315-329.
34. WANSAPURA, J.P. et al. 1999. NMR relaxation times in the human brain at 3.0 tesla. J. Magn. Reson. Imaging 9: 531-538.
35. KUO, Y.T. et al. 2005. In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride. J. Magn. Reson. Imaging 21: 334-339.
36. MA, Y. et al. 2005.Athree-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience 135: 1203-1215.
37. MCDANIEL, B. et al. 2001. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. Neuroimage 14: 1244-1255.
38. DUNN, J.F. & Y. ZAIM-WADGHIRI. 1999. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 22: 1367-1371.
39. UTRIAINEN, A. et al. 2004. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum. Mol. Genet. 13: 2089-2099.
40. TEN, V.S. et al. 2004. Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke 35: 2183-2188.
41. WAINWRIGHT, M.S. et al. 2004. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann. Neurol. 56: 61-67.
42. CYR, M. et al. 2005. Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction. Neuroimage 26: 83-90.
43. DHENAIN, M., S.W. RUFFINS & R.E. JACOBS. 2001. Three-dimensional digital mouse atlas using high-resolution MRI. Dev. Biol. 232: 458-470.
44. KOVACEVIC, N. et al. 2005. A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb. Cortex 15: 639-645.
45. SOWELL, E.R. et al. 2003. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362: 1699-1707.
46. MAZZIOTTA, J.C. et al. 1995. Digital brain atlases. Trends Neurosci. 18: 210-211.
47. THOMPSON, P.M. et al. 1997. Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces. J. Comput. Assist. Tomogr. 21: 567-581.
48. TOGA, A.W. et al. 1996. Informatics and computational neuroanatomy. Proc.AMIA Annu. Fall Symp. 299-303.
49. WOODS, R.P. et al. 1999. Creation and use of a Talairach-compatible atlas for accurate, automated, nonlinear intersubject registration, and analysis of functional imaging data. Hum. Brain Mapp. 8: 73-79.
50. TOGA, A.W. et al. 1995. A 3D digital map of rat brain. Brain Res. Bull. 38: 77-85.
51. AVALE, M.E. et al. 2004. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol. Psychiatry. 9: 718-726.
52. MA, Y. et al. 2006. Magnetic Resonance Microscopy of a Mouse Model of Attention-Deficit-Hyperactivity Disorder: Role of D4 dopamine receptors. 14th International Society for Magnetic Resonance in Medicine, Seattle, WA.
53. BOCK, N.A. et al. 2006. In vivo magnetic resonance imaging and semiautomated image analysis extend the brain phenotype for cdf/cdf mice. J. Neurosci. 26: 4455-4459.
54. BENVENISTE, H. & S.J. BLACKBAND. 2006. Translational neuroscience and magnetic-resonance microscopy. Lancet Neurol. 5: 536-544.
55. LAURITZEN, M. 2005. Reading vascular changes in brain imaging: is dendritic calcium the key? Nat. Rev. Neurosci. 6: 77-85.
56. SCANNELL, J.W. et al. 1996. Visual motion processing in the anterior ectosylvian sulcus of the cat. J. Neurophysiol. 76: 895-907.
57. SCANNELL, J.W. & M.P. YOUNG. 1999. Neuronal population activity and functional imaging. Proc. Biol. Sci. 266: 875-881.
58. BADDELEY, R. et al. 1997. Responses of neurons in primary and inferior temporal visual cortices to natural scenes. Proc. Biol. Sci. 264: 1775-1783.
59. COSTA, R.M., D. COHEN & M.A. NICOLELIS. 2004. Differential corticostriatal plasticity during fast and slow motor skill learning in mice. Curr. Biol. 14: 1124-1134.
60. MUELLER, S.G. et al. 2005. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin. N. Am. 15: 869-877, xi-xii.
61. POULIN, P. & K.K. ZAKZANIS. 2002. In vivo neuroanatomy of Alzheimer's disease: evidence from structural and functional brain imaging. Brain Cogn. 49: 220-225.
62. PRVULOVIC, D. et al. 2005. Functional activation imaging in aging and dementia. Psychiatry Res. 140: 97-113.
63. ROMBOUTS, S. & P. SCHELTENS. 2005. Functional connectivity in elderly controls and AD patients using resting state fMRI: a pilot study. Curr. Alzheimer Res. 2: 115-116.
64. AUSTIN, V.C. et al. 2005. Confounding effects of anesthesia on functional activation in rodent brain: a study of halothane and alpha-chloralose anesthesia. Neuroimage 24: 92-100.
65. SKOUBIS, P.D. et al. 2006. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats. Neuroscience 137: 583-591.
66. SHYU, B.C. et al. 2004. BOLD response to direct thalamic stimulation reveals a functional connection between the medial thalamus and the anterior cingulate cortex in the rat. Magn. Reson. Med. 52: 47-55.
67. SHYU, B.C. et al. 2004. A method for direct thalamic stimulation in fMRI studies using a glass-coated carbon fiber electrode. J. Neurosci. Methods 137: 123-131.
68. MUEGGLER, T. et al. 2003. Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease. J. Neurosci. 23: 8231-8236.
69. WEISS, C. et al. 2002. Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice. Neurobiol. Dis. 11: 425-433.
70. PAUTLER, R.G. & A.P. KORETSKY. 2002. Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 16: 441-448.
71. PAUTLER, R.G., A.C. SILVA & A.P. KORETSKY. 1998. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 40: 740-748.
72. WADGHIRI, Y.Z. et al. 2004. Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain development. NMR Biomed. 17: 613-619.
73. YU, X. et al. 2005. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci. 8: 961-968.
74. SZEMA, A.M. et al. 2006. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am. J. Physiol. Lung Cell Mol. Physiol. 291(5): L880-L886.